Abstract
Mitral regurgitation (MR) is the most prevalent valvular heart disease in the Western world. Surgical repair is the gold standard for the treatment of degenerative MR in low-risk patients. Given the rising number of patients with functional MR and higher operative risk due to relevant comorbidities and increasing age, interventional approaches to repair or replace diseased mitral valves are on the rise. However, the complex anatomy and physiology of the mitral valve and its adjacent valve apparatus bear major challenges. To date, only the MitraClip device has been used in a large number of patients; however, several other devices and systems specifically targeted at different underlying pathologies of MR are currently under development. In addition to valve repair, the first steps toward mitral valve replacement have been taken. The present article reviews the current state of the art of interventional approaches to mitral valve disease and its future perspectives.
Zusammenfassung
Die Mitralklappeninsuffizienz ist das häufigste Klappenvitium in der westlichen Welt. Die chirurgische Mitralklappenrekonstruktion ist der Goldstandard für Patienten mit degenerativer Mitralklappeninsuffizienz und niedrigem operativem Risiko. Durch die steigende Zahl von Patienten mit funktioneller Mitralklappeninsuffizienz sowie Patienten mit höherem operativem Risiko aufgrund von relevanten Komorbiditäten und zunehmendem Alter sind interventionelle Ansätze zur Reparatur sowie zum Ersatz von erkrankten Mitralklappen notwendig. Die komplexe Anatomie und Physiologie der Mitralklappe sowie des Mitralklappenapparats erschweren die Entwicklung interventioneller Strategien. Bisher wurde nur das MitraClip-System bei einer nennenswerten Anzahl von Patienten eingesetzt, jedoch werden im Moment verschiedene andere Systeme und Technologien entwickelt, die speziell auf verschiedene pathophysiologische Mechanismen ausgerichtet sind. Darüber hinaus wurden erste Schritte in Richtung eines interventionellen Mitralklappenersatzes unternommen. Die vorliegende Übersichtsarbeit stellt aktuelle Entwicklungen und Zukunftsperspektiven der interventionellen Mitralklappentherapie dar.
Similar content being viewed by others
Abbreviations
- 6MWT:
-
6-min walk test
- CS:
-
coronary sinus
- LA:
-
left atrium
- LV:
-
left ventricle
- LVOT:
-
left ventricular outflow tract
- MV:
-
mitral valve
- MR:
-
mitral regurgitation
- DMR:
-
degenerative mitral regurgitation
- FMR:
-
functional mitral regurgitation
- TAVI:
-
transcatheter aortic valve implantation
- TMV:
-
transcatheter mitral valve
- TMVI:
-
transcatheter mitral valve implantation
References
Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M (2006) Burden of valvular heart diseases: a population-based study. Lancet 368(9540):1005–1011. doi:10.1016/S0140-6736(06)69208-8
Enriquez-Sarano M, Akins CW, Vahanian A (2009) Mitral regurgitation. Lancet 373(9672):1382–1394. doi:10.1016/S0140-6736(09)60692-9
Ling LH, Enriquez-Sarano M, Seward JB, Tajik AJ, Schaff HV, Bailey KR, Frye RL (1996) Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 335(19):1417–1423. doi:10.1056/NEJM199611073351902
Gammie JS, Sheng S, Griffith BP, Peterson ED, Rankin JS, O’Brien SM, Brown JM (2009) Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Database. Ann Thorac Surg 87(5):1431–1439. doi:10.1016/j.athoracsur.2009.01.064
Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM (2005) Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 45(3):381–387. doi:10.1016/j.jacc.2004.09.073
Diodato MD, Moon MR, Pasque MK, Barner HB, Moazami N, Lawton JS, Bailey MS, Guthrie TJ, Meyers BF, Damiano RJ Jr (2004) Repair of ischemic mitral regurgitation does not increase mortality or improve long-term survival in patients undergoing coronary artery revascularization: a propensity analysis. Ann Thorac Surg 78(3):794–799. doi:10.1016/j.athoracsur.2004.03.022
Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Detaint D, Vanoverschelde JL, Butchart EG, Ravaud P, Vahanian A (2007) What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 28(11):1358–1365. doi:10.1093/eurheartj/ehm001
Thyregod HG, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, Chang Y, Franzen OW, Engstrom T, Clemmensen P, Hansen PB, Andersen LW, Olsen PS, Sondergaard L (2015) Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol 65(20):2184–2194. doi:10.1016/j.jacc.2015.03.014
Grasso C, Baldus S (2015) The MitraClip transcatheter mitral valve repair system. EuroIntervention 11(Suppl W):W45–W46. doi:10.4244/EIJV11SWA11
Siminiak T, Wu JC, Haude M, Hoppe UC, Sadowski J, Lipiecki J, Fajadet J, Shah AM, Feldman T, Kaye DM, Goldberg SL, Levy WC, Solomon SD, Reuter DG (2012) Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail 14(8):931–938. doi:10.1093/eurjhf/hfs076
Schofer J, Siminiak T, Haude M, Herrman JP, Vainer J, Wu JC, Levy WC, Mauri L, Feldman T, Kwong RY, Kaye DM, Duffy SJ, Tubler T, Degen H, Brandt MC, Van Bibber R, Goldberg S, Reuter DG, Hoppe UC (2009) Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation 120(4):326–333. doi:10.1161/CIRCULATIONAHA.109.849885
Maisano F, La Canna G, Latib A, Denti P, Taramasso M, Kuck KH, Colombo A, Alfieri O, Guidotti A, Messika-Zeitoun D, Vahanian A (2014) First-in-man transseptal implantation of a “surgical-like” mitral valve annuloplasty device for functional mitral regurgitation. JACC Cardiovasc Interv 7(11):1326–1328. doi:10.1016/j.jcin.2014.08.003
Maisano F, Taramasso M (2015) The Cardioband transcatheter direct mitral valve annuloplasty system. EuroIntervention 11(Suppl W):W58–59. doi:10.4244/EIJV11SWA15
Siminiak T, Dankowski R, Baszko A, Lee C, Firek L, Kalmucki P, Szyszka A, Groothuis A (2013) Percutaneous direct mitral annuloplasty using the Mitralign Bident system: description of the method and a case report. Kardiol Pol 71(12):1287–1292. doi:10.5603/KP.2013.0325
Rogers JH, Thomas M, Morice MC, Narbute I, Zabunova M, Hovasse T, Poupineau M, Rudzitis A, Kamzola G, Zvaigzne L, Greene S, Erglis A (2015) Treatment of heart failure with associated functional mitral regurgitation using the ARTO System: initial results of the First-in-Human MAVERIC Trial (Mitral Valve Repair Clinical Trial). JACC Cardiovasc Interv 8(8):1095–1104. doi:10.1016/j.jcin.2015.04.012
Maisano F, Cioni M, Seeburger J, Falk V, Mohr FW, Mack MJ, Alfieri O, Vanermen H (2011) Beating-heart implantation of adjustable length mitral valve chordae: acute and chronic experience in an animal model. Eur J Cardiothorac Surg 40(4):840–847. doi:10.1016/j.ejcts.2011.01.021
Seeburger J, Rinaldi M, Nielsen SL, Salizzoni S, Lange R, Schoenburg M, Alfieri O, Borger MA, Mohr FW, Aidietis A (2014) Off-pump transapical implantation of artificial neo-chordae to correct mitral regurgitation: the TACT Trial (Transapical Artificial Chordae Tendinae) proof of concept. J Am Coll Cardiol 63(9):914–919. doi:10.1016/j.jacc.2013.07.090
Rucinskas K, Janusauskas V, Zakarkaite D, Aidietiene S, Samalavicius R, Speziali G, Aidietis A (2014) Off-pump transapical implantation of artificial chordae to correct mitral regurgitation: early results of a single-center experience. J Thorac Cardiovasc Surg 147(1):95–99. doi:10.1016/j.jtcvs.2013.08.012
Raval J, Nagaraja V, Eslick GD, Denniss AR (2014) Transcatheter valve-in-valve implantation: a systematic review of literature. Heart Lung Circ 23(11):1020–1028. doi:10.1016/j.hlc.2014.06.001
Hasan R, Mahadevan VS, Schneider H, Clarke B (2013) First in human transapical implantation of an inverted transcatheter aortic valve prosthesis to treat native mitral valve stenosis. Circulation 128(6):e74–e76. doi:10.1161/CIRCULATIONAHA.113.001466
Fassa AA, Himbert D, Brochet E, Depoix JP, Cheong AP, Alkhoder S, Nataf P, Vahanian A (2014) Transseptal transcatheter mitral valve implantation for severely calcified mitral stenosis. JACC Cardiovasc Interv 7(6):696–697. doi:10.1016/j.jcin.2013.12.204
Nielsen NE, Baranowski J, Ahn HC (2015) Transvenous Implantation of a Stent Valve for Calcified Native Mitral Stenosis. Ann Thorac Surg 100(1):e21–e23. doi:10.1016/j.athoracsur.2015.03.114
Guerrero M, Greenbaum A, O’Neill W (2014) First in human percutaneous implantation of a balloon expandable transcatheter heart valve in a severely stenosed native mitral valve. Catheter Cardiovasc Interv 83(7):E287–E291. doi:10.1002/ccd.25441
Cheung A, Webb J, Verheye S, Moss R, Boone R, Leipsic J, Ree R, Banai S (2014) Short-term results of transapical transcatheter mitral valve implantation for mitral regurgitation. J Am Coll Cardiol 64(17):1814–1819. doi:10.1016/j.jacc.2014.06.1208
Bapat V, Buellesfeld L, Peterson MD, Hancock J, Reineke D, Buller C, Carrel T, Praz F, Rajani R, Fam N, Kim H, Redwood S, Young C, Munns C, Windecker S, Thomas M (2014) Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device. EuroIntervention 10(Suppl U):U120–U128. doi:10.4244/EIJV10SUA18
Cheung A, Stub D, Moss R, Boone RH, Leipsic J, Verheye S, Banai S, Webb J (2014) Transcatheter mitral valve implantation with Tiara bioprosthesis. EuroIntervention 10(Suppl U):U115–119. doi:10.4244/EIJV10SUA17
Moat N, Duncan A, Lindsay A, Quarto C, Blanke P, Leipsic J, Grayburn P, Davies S (2015) Transcatheter mitral valve replacement for the treatment of mitral regurgitation: in-hospital outcomes of an apically tethered device. J Am Coll Cardiol 65(21):2352–2353. doi:10.1016/j.jacc.2015.01.066
Ussia GP, Quadri A, Cammalleri V, De Vico P, Muscoli S, Marchei M, Ruvolo G, Sondergaard L, Romeo F (2015) Percutaneous transfemoral-transseptal implantation of a second-generation CardiAQ mitral valve bioprosthesis: first procedure description and 30-day follow-up. EuroIntervention 11(5). doi:10.4244/EIJY15M09_01
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
V. Mauri, S. Baldus, and V. Rudolph state that there are no conflicts of interest.
Rights and permissions
About this article
Cite this article
Mauri, V., Baldus, S. & Rudolph, V. Interventional approaches to mitral regurgitation. Herz 41, 26–30 (2016). https://doi.org/10.1007/s00059-015-4384-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-015-4384-2
Keywords
- Mitral regurgitation
- Transcatheter mitral valve repair
- Transcatheter mitral valve replacement
- MitraClip
- Review